InvestorsHub Logo
Followers 32
Posts 10384
Boards Moderated 0
Alias Born 04/20/2016

Re: rawman post# 44592

Friday, 02/16/2018 12:17:30 PM

Friday, February 16, 2018 12:17:30 PM

Post# of 54031
Do you understand trials have phases? When NIH release results this year that could be a major catalyst to increase value of AV101. Agn bought Naurex drug after phase 2.

Sage went up 2 bil in market cap after phase 2 study.. Alchemey is flying.

Will be buyout mania in biotech’s shortly and depression is a hot area.

Plus it is virtually a risk free investment by TAUG